Technology | Advanced Visualization | September 20, 2016

Device offers superior nodule detection performance and faster reading using a concurrent read for lung CT screening

Riverain Technologies, ClearRead CT, lung nodule detection software, FDA approval

September 20, 2016 — Riverain Technologies announced that its ClearRead CT, a breakthrough lung nodule detection application, has received clearance from the U.S. Food and Drug Administration (FDA).

ClearRead CT is the only FDA-cleared device to support concurrent reading, allowing for faster reading with proven superior automatic nodule detection performance for all primary nodule types, including solid, sub-solid and ground glass nodules.

ClearRead CT, powered by acquisition normalization technology, provides an enterprise-ready solution for the entire healthcare network. The technology seamlessly processes computed tomography (CT) scans from a wide range of manufacturers and acquisition protocols, and quickly installs into the clinical environment without the need for new hardware or customized tuning to specific devices or protocols.

ClearRead CT was evaluated in a multi-reader, multi-case clinical trial and showed radiologists achieved a 29 percent reduction in missed actionable nodules, while reducing reading time by 26 percent.

The software is comprised of two tools: ClearRead CT | Vessel Suppress and ClearRead CT | Detect. Deep learning enables the vessel suppression technology to assist both machine and humans in the detection and characterization of all primary nodule types, allowing for previously unattained nodule detection performance.

ClearRead CT is available for sale in the United States, Canada and Europe.

For more information: www.riveraintech.com


Related Content

News | Computed Tomography (CT)

April 17, 2025 — NANO-X IMAGING LTD has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Time April 18, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | PACS

April 3, 2025 – Konica Minolta Healthcare Americas, Inc. has launched the next-generation of the Exa Platform with the ...

Time April 15, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Enterprise Imaging

Nov. 13, 2024 – Konica Minolta Healthcare Americas, Inc.has launched Exa Enterprise, an enterprise imaging solution with ...

Time November 14, 2024
arrow
News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Subscribe Now